Smoking Cessation Aids Market Global Industry Perspective, Comprehensive Analysis and Forecast
Global Smoking Cessation Aids Market is expected to grow at a high CAGR during the forecasting period (2021-2028).
(EMAILWIRE.COM, October 18, 2021 )
Market Overview
Tobacco use can lead to tobacco/nicotine dependence and serious health problems. Quitting smoking greatly decreases the risk of developing smoking-related diseases. Tobacco/nicotine dependence is a condition that often requires repeated treatments, but there are helpful treatments and resources for quitting.
Tobacco smoke contains a deadly mix of more than 7,000 chemicals, of which hundreds are harmful, and about 70 can cause cancer. Smoking increases, therefore, increases the risk of serious health problems, many diseases, and death. People who stop smoking greatly reduce their risk of disease and early death.
View full report: https://www.datamintelligence.com/research-report/smoking-cessation-aids-market
Market Dynamics
The global smoking cessation aids market growth is driven by the rising addiction toward tobacco smoking, increasing number of campaigns to reduce smoking and tobacco dependence are some of the factors driving the market growth.
Rising awareness about smoking cessation therapy is expected to drive the market growth
Smoking is one of the major causes of lung cancer and other respiratory and cardiac diseases. Awareness about these health hazards has influenced individuals to adopt smoking cessation therapy. The awareness among the individuals is through digital media, print media, and other sources of information have proved to be effective in curbing the nicotine addiction crisis to some extent.
Cigarette smoking remains the leading cause of preventable disease, disability, and death. According to the Centers for Disease Control and Prevention (CDC), In 2019, nearly 14 of every 100 U.S. adults aged 18 years or older (14.0%) smoked cigarettes. This hints at a high usage of de-addiction products.
Also, this depicts the growing awareness of the people and their readiness to quit smoking. There are also non-government and government establishments are working to educate and help people quit smoking that is engaged dedicatedly to bring the number of smokers down.
For instance, in 2017, the U.S. Food and Drug Administration launched an adult smoking cessation education campaign to encourage cigarette smokers to quit smoking.
Market Segmentation
Global Smoking Cessation Aids Market By Product
Nicotine Replacement Therapy
o NRT Gum
o NRT lozenges
o NRT Inhalers
o NRT Patches
o Nicotine nasal sprays
Medications
o Bupropion
o Varenicline
Electronic Cigarettes
Heat-not-burn Tobacco Products
Others
Global Smoking Cessation Aids Market By Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Others
Global Smoking Cessation Aids Market - By Region
North America
Europe
Asia-Pacific
Middle East & Africa
South America
Download free sample: https://www.datamintelligence.com/download-sample/smoking-cessation-aids-market
Competitive Landscape
The global smoking cessation aids market is highly competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Takeda Pharmaceutical Company Limited, NJOY, Pfizer Inc, Cipla Ltd, GlaxoSmithKline Plc, Dr. Reddy's Laboratories, Juul Labs, Glenmark, Perrigo Company plc, Johnson and Johnson Services, Inc and Imperial Brands.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, in July 2020, Dr. Reddy's Laboratories launched OTC Nicotine Polacrilex Lozenges in the United States. The Nicotine lozenges brands and store brand markets witnessed United States retail sales of about USD 200 million in 2020. The product is a significant addition to the companys offering of Nicotine Replacement Therapy.
Topic's you may be interested, Dysthymia Drugs Market, Benzodiazepine Drugs Market, Chondroitin Sulfate Market, Artemisinin Combination Therapy Market, Tapentadol Market
Market Overview
Tobacco use can lead to tobacco/nicotine dependence and serious health problems. Quitting smoking greatly decreases the risk of developing smoking-related diseases. Tobacco/nicotine dependence is a condition that often requires repeated treatments, but there are helpful treatments and resources for quitting.
Tobacco smoke contains a deadly mix of more than 7,000 chemicals, of which hundreds are harmful, and about 70 can cause cancer. Smoking increases, therefore, increases the risk of serious health problems, many diseases, and death. People who stop smoking greatly reduce their risk of disease and early death.
View full report: https://www.datamintelligence.com/research-report/smoking-cessation-aids-market
Market Dynamics
The global smoking cessation aids market growth is driven by the rising addiction toward tobacco smoking, increasing number of campaigns to reduce smoking and tobacco dependence are some of the factors driving the market growth.
Rising awareness about smoking cessation therapy is expected to drive the market growth
Smoking is one of the major causes of lung cancer and other respiratory and cardiac diseases. Awareness about these health hazards has influenced individuals to adopt smoking cessation therapy. The awareness among the individuals is through digital media, print media, and other sources of information have proved to be effective in curbing the nicotine addiction crisis to some extent.
Cigarette smoking remains the leading cause of preventable disease, disability, and death. According to the Centers for Disease Control and Prevention (CDC), In 2019, nearly 14 of every 100 U.S. adults aged 18 years or older (14.0%) smoked cigarettes. This hints at a high usage of de-addiction products.
Also, this depicts the growing awareness of the people and their readiness to quit smoking. There are also non-government and government establishments are working to educate and help people quit smoking that is engaged dedicatedly to bring the number of smokers down.
For instance, in 2017, the U.S. Food and Drug Administration launched an adult smoking cessation education campaign to encourage cigarette smokers to quit smoking.
Market Segmentation
Global Smoking Cessation Aids Market By Product
Nicotine Replacement Therapy
o NRT Gum
o NRT lozenges
o NRT Inhalers
o NRT Patches
o Nicotine nasal sprays
Medications
o Bupropion
o Varenicline
Electronic Cigarettes
Heat-not-burn Tobacco Products
Others
Global Smoking Cessation Aids Market By Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Others
Global Smoking Cessation Aids Market - By Region
North America
Europe
Asia-Pacific
Middle East & Africa
South America
Download free sample: https://www.datamintelligence.com/download-sample/smoking-cessation-aids-market
Competitive Landscape
The global smoking cessation aids market is highly competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Takeda Pharmaceutical Company Limited, NJOY, Pfizer Inc, Cipla Ltd, GlaxoSmithKline Plc, Dr. Reddy's Laboratories, Juul Labs, Glenmark, Perrigo Company plc, Johnson and Johnson Services, Inc and Imperial Brands.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, in July 2020, Dr. Reddy's Laboratories launched OTC Nicotine Polacrilex Lozenges in the United States. The Nicotine lozenges brands and store brand markets witnessed United States retail sales of about USD 200 million in 2020. The product is a significant addition to the companys offering of Nicotine Replacement Therapy.
Topic's you may be interested, Dysthymia Drugs Market, Benzodiazepine Drugs Market, Chondroitin Sulfate Market, Artemisinin Combination Therapy Market, Tapentadol Market
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results